#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma recurrent Familial amyotrophic lateral sclerosis Laryngeal squamous cell carcinoma Sarcoma Adenovirus infection Infertility female Wolfram syndrome Congenital hypotransferrinaemia Cutaneous T-cell lymphoma Atypical haemolytic uraemic syndrome Oesophageal squamous cell carcinoma stage II Acute graft versus host disease Gestational trophoblastic tumour Small cell lung cancer limited stage Oesophageal adenocarcinoma More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Life with Disease Mucous membrane pemphigoid – Basic Information Noonan syndrome – Basic Information Combined immunodeficiency – Treatment Lennox-Gastaut syndrome – Diagnostics Antithrombin III deficiency – Diagnostics Nephrotic syndrome – Diagnostics Hereditary angioedema Propionic acidaemia – Diagnostics Hairy cell leukaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivacaftor Tomligisiran Candesartan Sodium Glycocholate Colestyramine Obinutuzumab Zagociguat OMTX705 Salbutamol Sulfate Ph. Eur. Betahistine Dihydrochloride Fosfomycin Trometamol Bulevirtide ADCE-D01 IHMA-2121771-2 Cln-081 Valsartan Basimglurant Tafamidis Methylprednisolone Acetate Ligelizumab More therapies…

    Learn about Your Condition

    Cerebral palsy Brain abscess Inner ear disorder Eye pain Apathy Lip and/or oral cavity cancer Immunodeficiency congenital Hepatic adenoma Primary hyperaldosteronism Primary adrenal insufficiency Drug use disorder Ewing's sarcoma recurrent Decreased appetite Hepatobiliary disease Neurodegenerative disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study of irinotecan and a drug combination for patients with gastric cancer or gastroesophageal junction cancer undergoing surgery.

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • A study to evaluate the effect of rimegepant in patients with migraine and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Rimegepant
    Austria

  • A study to evaluate the effectiveness and safety of Usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • USNOFLAST
    Belgium France Germany Ireland Italy The Netherlands +3

  • A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Bulgaria Greece Hungary Norway Romania Spain

  • A study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Methylprednisolone
    • Sodium Chloride
    Denmark

  • A study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease

    Recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    • Interstitial lung disease
    Investigated Drugs:
    • Treprostinil
    Austria Belgium Czechia France Germany Italy +4
Previous Page
1 … 44 45 46 47 48 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!